Approaches to drug therapy in older cancer patients
- PMID: 1532740
Approaches to drug therapy in older cancer patients
Abstract
Cancer in the elderly is an increasing social and medical problem. More than 50% of all cancers and cancer deaths occur in patients over age 65. The treating physician must not only carefully evaluate these patients relative to their neoplasm (careful history and physical exam, appropriate laboratory investigations), but also must assess any comorbid conditions that can impact upon drug toxicity or overall survival expectations. This article will discuss recommendations for chemotherapy in the elderly in regard to individual drugs as well as strategies for particular cancers. Although this will provide background information, it is still imperative to discuss therapy with the patient concerning his or her wishes and expectations before individual therapy is initiated. This is neither more nor less valid for the elderly patient than for any other patient with malignancy.
Similar articles
-
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.Oncologist. 1996;1(5):326-330. Oncologist. 1996. PMID: 10388011
-
Cancer, clinical pharmacology, and aging.Clin Geriatr Med. 1987 Aug;3(3):483-503. Clin Geriatr Med. 1987. PMID: 3308046 Review.
-
"Just Another Statistic".Oncologist. 1998;3(3):III-IV. Oncologist. 1998. PMID: 10388105
-
Clinical pharmacology issues relevant to the dosing and toxicity of chemotherapy drugs in the elderly.Oncologist. 2005 Sep;10(8):602-12. doi: 10.1634/theoncologist.10-8-602. Oncologist. 2005. PMID: 16177284 Review.
-
Chemotherapy in older cancer patients.Oncology (Williston Park). 1992 Feb;6(2 Suppl):74-80. Oncology (Williston Park). 1992. PMID: 1532741 Review.
Cited by
-
Defining treatment aims and end-points in older patients with cancer.Drugs Aging. 1995 May;6(5):351-7. doi: 10.2165/00002512-199506050-00002. Drugs Aging. 1995. PMID: 7647424 Review. No abstract available.
-
Relation between age and clearance rate of nine investigational anticancer drugs from phase I pharmacokinetic data.Cancer Chemother Pharmacol. 1994;33(6):493-6. doi: 10.1007/BF00686507. Cancer Chemother Pharmacol. 1994. PMID: 8137460
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical